Could not connect to DB: 1040: Too many connectionsCould not execute 'UPDATE pressrelease SET r_hits = r_hits+ 1, r_total_hits = r_total_hits+ 1, r_pub_hits = r_pub_hits+ 1, r_total_pub_hits = r_total_pub_hits+ 1 WHERE r_id = 162493' on database eurekalert:
2002: Can't connect to local MySQL server through socket '/tmp/mysql.sock' (2) [ Back to EurekAlert! ] Public release date: 10-Jun-2010
[ | E-mail Share Share ]

Contact: Tom Reller
T.Reller@elsevier.com
215-239-3508
Elsevier

Elsevier acquires Collexis

Acquisition accelerates Elsevier's ability to help researchers and decision-makers, establish, execute and evaluate research strategies and deliver higher ROI

Amsterdam, 10 June, 2010 - Elsevier (www.elsevier.com), the leading global publisher of scientific, technical, and medical information products and services, announced today the acquisition of assets from Collexis Holdings, Inc. (www.collexis.com), a leading developer of semantic technology and knowledge discovery software. The combination of Elsevier's content and Collexis' semantic technology will provide institutions and researchers new ways to collaborate, showcase accomplishments and improve grant related workflow efficiencies.

"Elsevier's research performance, planning and funding (PPF) strategy, delivered through our SciVal suite of research tools and integrated workflow solutions, helps accelerate scientific discovery and improve the social and economic impact of research while improving research driven ROI," said Jay Katzen, Managing Director, Elsevier Science and Technology. "By combining Collexis' solutions that address several PPF pain points across our customer's collaboration, funding and strategic planning initiatives and SciVal, we've created a unique set of solutions that enable Universities and Government agencies to improve research outcomes."

Collexis technology is considered market leading in the academic segment; well architected and thoughtfully developed over time. Main products include:

Collexis Holdings, Inc. is headquartered in Columbia, South Carolina with operations in Cologne, Germany and Valparaiso, Chile. The acquisition is effective immediately and terms of the agreement are not being disclosed.

###

About Elsevier

Elsevier is a world-leading publisher of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including the Lancet (www.thelancet.com) and Cell (www.cell.com), and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect (www.sciencedirect.com), Scopus (www.scopus.com), Reaxys (www.reaxys.com), MD Consult (www.mdconsult.com) and Nursing Consult (www.nursingconsult.com), which enhance the productivity of science and health professionals, and the SciVal suite (www.scival.com) and MEDai's Pinpoint Review (www.medai.com), which help research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier (www.elsevier.com) employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC (www.reedelsevier.com), a world-leading publisher and information provider. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).



[ Back to EurekAlert! ] [ | E-mail Share Share ]

 


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.